InsiderSource
UTHR

UNITED THERAPEUTICS Corp

SEC CIK 1082554
$536.59 +13.4% · 90 days
90-day buys
$0
0 open-market
90-day sells
$272.52M
521 open-market
Net insider flow
−$272.52M
Net selling
Filings shown
726
Most recent
Advertisement

At a glance

Over the last 90 days, insiders at UTHR have sold a net $272.52M of stock (0 open-market buys vs 521 sells).

Largest recent trade: Mahon Paul A sold $2.88M of UTHR, trimming their stake 17%.

Most active filer: Rothblatt Martine A, with 428 transactions among the recent filings shown.

Insider transaction history

Form 4 filings for UTHR, newest first
View on SEC EDGAR ↗
UTHR
UNITED THERAPEUTICS Corp
Sell EDGEMOND JAMES · CFO AND TREASURER · Open-market sale · filed 2w ago ΔOwn −1.7%

Edgemond James sold $259.7K of UTHR, trimming their stake 2%.

−$259.7K
480 sh @ $541
UTHR
UNITED THERAPEUTICS Corp
Sell EDGEMOND JAMES · CFO AND TREASURER · Open-market sale · filed 2w ago ΔOwn −1.6%

Edgemond James sold $238.8K of UTHR, trimming their stake 2%.

−$238.8K
440 sh @ $543
Advertisement
UTHR
UNITED THERAPEUTICS Corp
Sell EDGEMOND JAMES · CFO AND TREASURER · Open-market sale · filed 2w ago ΔOwn −3.9%

Edgemond James sold $590.9K of UTHR, trimming their stake 4%.

−$590.9K
1,086 sh @ $544
UTHR
UNITED THERAPEUTICS Corp
Sell EDGEMOND JAMES · CFO AND TREASURER · Open-market sale · filed 2w ago ΔOwn −5.8%

Edgemond James sold $841.9K of UTHR, trimming their stake 6%.

−$841.9K
1,545 sh @ $545
UTHR
UNITED THERAPEUTICS Corp
Sell EDGEMOND JAMES · CFO AND TREASURER · Open-market sale · filed 2w ago ΔOwn −4.5%

Edgemond James sold $616.3K of UTHR, trimming their stake 4%.

−$616.3K
1,129 sh @ $546
UTHR
UNITED THERAPEUTICS Corp
Sell EDGEMOND JAMES · CFO AND TREASURER · Open-market sale · filed 2w ago ΔOwn −4.3%

Edgemond James sold $565.1K of UTHR, trimming their stake 4%.

−$565.1K
1,033 sh @ $547
UTHR
UNITED THERAPEUTICS Corp
Sell EDGEMOND JAMES · CFO AND TREASURER · Open-market sale · filed 2w ago ΔOwn −12%

Edgemond James sold $1.51M of UTHR, trimming their stake 12%.

−$1.51M
2,749 sh @ $548
UTHR
UNITED THERAPEUTICS Corp
Sell EDGEMOND JAMES · CFO AND TREASURER · Open-market sale · filed 2w ago ΔOwn −6.4%

Edgemond James sold $712.7K of UTHR, trimming their stake 6%.

−$712.7K
1,298 sh @ $549
UTHR
UNITED THERAPEUTICS Corp
Sell EDGEMOND JAMES · CFO AND TREASURER · Open-market sale · filed 2w ago ΔOwn −0.6%

Edgemond James sold $66.1K of UTHR, trimming their stake 1%.

−$66.1K
120 sh @ $550
UTHR
UNITED THERAPEUTICS Corp
Sell ROTHBLATT MARTINE A · Director, Chairperson & CEO · Open-market sale · filed 2w ago ΔOwn −0.9%

Rothblatt Martine A sold $255.9K of UTHR, trimming their stake 1%.

−$255.9K
473 sh @ $541
UTHR
UNITED THERAPEUTICS Corp
Sell ROTHBLATT MARTINE A · Director, Chairperson & CEO · Open-market sale · filed 2w ago ΔOwn −0.8%

Rothblatt Martine A sold $215.1K of UTHR, trimming their stake 1%.

−$215.1K
396 sh @ $543
UTHR
UNITED THERAPEUTICS Corp
Sell ROTHBLATT MARTINE A · Director, Chairperson & CEO · Open-market sale · filed 2w ago ΔOwn −3.0%

Rothblatt Martine A sold $800K of UTHR, trimming their stake 3%.

−$800K
1,470 sh @ $544
UTHR
UNITED THERAPEUTICS Corp
Sell ROTHBLATT MARTINE A · Director, Chairperson & CEO · Open-market sale · filed 2w ago ΔOwn −2.5%

Rothblatt Martine A sold $646.6K of UTHR, trimming their stake 2%.

−$646.6K
1,186 sh @ $545
UTHR
UNITED THERAPEUTICS Corp
Sell ROTHBLATT MARTINE A · Director, Chairperson & CEO · Open-market sale · filed 2w ago ΔOwn −2.6%

Rothblatt Martine A sold $656.5K of UTHR, trimming their stake 3%.

−$656.5K
1,202 sh @ $546
UTHR
UNITED THERAPEUTICS Corp
Sell ROTHBLATT MARTINE A · Director, Chairperson & CEO · Open-market sale · filed 2w ago ΔOwn −3.4%

Rothblatt Martine A sold $835K of UTHR, trimming their stake 3%.

−$835K
1,525 sh @ $548
UTHR
UNITED THERAPEUTICS Corp
Sell ROTHBLATT MARTINE A · Director, Chairperson & CEO · Open-market sale · filed 2w ago ΔOwn −3.9%

Rothblatt Martine A sold $918.9K of UTHR, trimming their stake 4%.

−$918.9K
1,676 sh @ $548
UTHR
UNITED THERAPEUTICS Corp
Sell ROTHBLATT MARTINE A · Director, Chairperson & CEO · Open-market sale · filed 2w ago ΔOwn −1.9%

Rothblatt Martine A sold $428.4K of UTHR, trimming their stake 2%.

−$428.4K
780 sh @ $549
UTHR
UNITED THERAPEUTICS Corp
Sell ROTHBLATT MARTINE A · Director, Chairperson & CEO · Open-market sale · filed 2w ago ΔOwn −1.4%

Rothblatt Martine A sold $308.3K of UTHR, trimming their stake 1%.

−$308.3K
560 sh @ $550
UTHR
UNITED THERAPEUTICS Corp
Sell MAHON PAUL A · EVP & GENERAL COUNSEL · Open-market sale · filed 2w ago ΔOwn −0.4%

Mahon Paul A sold $108K of UTHR.

−$108K
200 sh @ $540
UTHR
UNITED THERAPEUTICS Corp
Sell MAHON PAUL A · EVP & GENERAL COUNSEL · Open-market sale · filed 2w ago ΔOwn −1.6%

Mahon Paul A sold $456.9K of UTHR, trimming their stake 2%.

−$456.9K
840 sh @ $544
UTHR
UNITED THERAPEUTICS Corp
Sell MAHON PAUL A · EVP & GENERAL COUNSEL · Open-market sale · filed 2w ago ΔOwn −0.7%

Mahon Paul A sold $203.9K of UTHR, trimming their stake 1%.

−$203.9K
374 sh @ $545
UTHR
UNITED THERAPEUTICS Corp
Sell MAHON PAUL A · EVP & GENERAL COUNSEL · Open-market sale · filed 2w ago ΔOwn −5.0%

Mahon Paul A sold $1.44M of UTHR, trimming their stake 5%.

−$1.44M
2,627 sh @ $546
UTHR
UNITED THERAPEUTICS Corp
Sell MAHON PAUL A · EVP & GENERAL COUNSEL · Open-market sale · filed 2w ago ΔOwn −1.9%

Mahon Paul A sold $511.5K of UTHR, trimming their stake 2%.

−$511.5K
935 sh @ $547
Advertisement

About UTHR insider activity

This page tracks every recent Form 4 filed for UNITED THERAPEUTICS Corp with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.

The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.

Frequently asked questions

How often is UTHR insider data updated?

Continuously. We read from SEC EDGAR, so new Form 4 filings for UNITED THERAPEUTICS Corp usually appear here within minutes of being accepted by the SEC.

What does "net insider flow" mean?

It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.

Why do some rows show grants or option exercises instead of buys?

Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.

Is this investment advice?

No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.